Kazuma Iekushi

2.4k total citations
43 papers, 1.3k citations indexed

About

Kazuma Iekushi is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Kazuma Iekushi has authored 43 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 11 papers in Molecular Biology and 10 papers in Surgery. Recurrent topics in Kazuma Iekushi's work include Atrial Fibrillation Management and Outcomes (8 papers), Liver physiology and pathology (7 papers) and Erythropoietin and Anemia Treatment (6 papers). Kazuma Iekushi is often cited by papers focused on Atrial Fibrillation Management and Outcomes (8 papers), Liver physiology and pathology (7 papers) and Erythropoietin and Anemia Treatment (6 papers). Kazuma Iekushi collaborates with scholars based in Japan, Germany and Switzerland. Kazuma Iekushi's co-authors include Ryuichi Morishita, Junya Azuma, Yoshiaki Taniyama, Fumihiro Sanada, Stefanie Dimmeler, Andreas M. Zeiher, Hiromi Rakugi, Keita Okayama, Florian Seeger and Hiroshi Kusunoki and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Circulation Research.

In The Last Decade

Kazuma Iekushi

41 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kazuma Iekushi Japan 22 488 454 295 192 152 43 1.3k
Andrei Seferian France 18 272 0.6× 411 0.9× 157 0.5× 76 0.4× 68 0.4× 45 1.5k
Neil Davie United Kingdom 18 415 0.9× 880 1.9× 270 0.9× 203 1.1× 57 0.4× 41 2.0k
Roger van Kruchten Netherlands 14 387 0.8× 325 0.7× 233 0.8× 77 0.4× 105 0.7× 18 1.6k
Yukihiro Hojo Japan 25 604 1.2× 659 1.5× 369 1.3× 241 1.3× 32 0.2× 56 1.6k
Mélanie Eyries France 23 438 0.9× 557 1.2× 343 1.2× 167 0.9× 37 0.2× 54 1.9k
Pierre Zoldhelyi United States 17 380 0.8× 474 1.0× 410 1.4× 121 0.6× 180 1.2× 34 1.2k
Jay M. Edelberg United States 16 479 1.0× 305 0.7× 591 2.0× 470 2.4× 114 0.8× 31 1.6k
Benoît Ranchoux France 14 535 1.1× 423 0.9× 169 0.6× 236 1.2× 23 0.2× 17 1.4k
Clément Nguyen France 12 648 1.3× 194 0.4× 182 0.6× 175 0.9× 26 0.2× 19 1.4k
Yacine Boulaftali France 23 421 0.9× 334 0.7× 165 0.6× 210 1.1× 244 1.6× 47 1.7k

Countries citing papers authored by Kazuma Iekushi

Since Specialization
Citations

This map shows the geographic impact of Kazuma Iekushi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuma Iekushi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuma Iekushi more than expected).

Fields of papers citing papers by Kazuma Iekushi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuma Iekushi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuma Iekushi. The network helps show where Kazuma Iekushi may publish in the future.

Co-authorship network of co-authors of Kazuma Iekushi

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuma Iekushi. A scholar is included among the top collaborators of Kazuma Iekushi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuma Iekushi. Kazuma Iekushi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Takahashi, Yuri, Takeshi Morimoto, Kazuma Iekushi, & Hidenori Arai. (2024). A Medical Claims Database Study of Factors Associated with Medication Adherence and Treatment Persistence in Patients Receiving PCSK9 Monoclonal Antibodies. Journal of Atherosclerosis and Thrombosis. 32(2). 163–175. 1 indexed citations
3.
4.
5.
Akizawa, Tadao, Iain C. Macdougall, Jeffrey S. Berns, et al.. (2019). Iron Regulation by Molidustat, a Daily Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, in Patients with Chronic Kidney Disease. ˜The œNephron journals/Nephron journals. 143(4). 243–254. 25 indexed citations
6.
Hori, Masatsugu, Masayasu Matsumoto, Norio Tanahashi, et al.. (2016). Predictive factors for bleeding during treatment with rivaroxaban and warfarin in Japanese patients with atrial fibrillation – Subgroup analysis of J-ROCKET AF. Journal of Cardiology. 68(6). 523–528. 13 indexed citations
7.
Taniyama, Yoshiaki, Naruto Katsuragi, Fumihiro Sanada, et al.. (2015). Selective Blockade of Periostin Exon 17 Preserves Cardiac Performance in Acute Myocardial Infarction. Hypertension. 67(2). 356–361. 54 indexed citations
8.
Yamada, Norikazu, Atsushi Hirayama, Hideaki Maeda, et al.. (2015). Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program. Thrombosis Journal. 13(1). 11–11. 79 indexed citations
9.
Hori, Masatsugu, Masayasu Matsumoto, Norio Tanahashi, et al.. (2014). Rivaroxaban vs. Warfarin in Japanese Patients With Non-Valvular Atrial Fibrillation in Relation to Age:– Insight From J-ROCKET AF –. Japanese Circulation Journal-english Edition. 78(6). 1349–1356. 3 indexed citations
10.
Matsumoto, Masayasu, Masatsugu Hori, Norio Tanahashi, et al.. (2014). Rivaroxaban versus warfarin in Japanese patients with non-valvular atrial fibrillation in relation to hypertension: a subgroup analysis of the J-ROCKET AF trial. Hypertension Research. 37(5). 457–462. 9 indexed citations
11.
Ogawa, Satoshi, Takanori Ikeda, Takanari Kitazono, et al.. (2014). Present Profiles of Novel Anticoagulant Use in Japanese Patients with Atrial Fibrillation: Insights from the Rivaroxaban Postmarketing Surveillance Registry. Journal of Stroke and Cerebrovascular Diseases. 23(10). 2520–2526. 22 indexed citations
12.
Hori, Masatsugu, Masayasu Matsumoto, Norio Tanahashi, et al.. (2013). Rivaroxaban versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation in Relation to the CHADS2 Score: A Subgroup Analysis of the J-ROCKET AF Trial. Journal of Stroke and Cerebrovascular Diseases. 23(2). 379–383. 13 indexed citations
13.
Uchiyama, Shinichiro, Masatsugu Hori, Masayasu Matsumoto, et al.. (2013). Net Clinical Benefit of Rivaroxaban versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation: A Subgroup Analysis of J-ROCKET AF. Journal of Stroke and Cerebrovascular Diseases. 23(5). 1142–1147. 11 indexed citations
14.
Xu, Quanfu, Florian Seeger, Kazuma Iekushi, et al.. (2012). Micro-RNA-34a Contributes to the Impaired Function of Bone Marrow-Derived Mononuclear Cells From Patients With Cardiovascular Disease. Journal of the American College of Cardiology. 59(23). 2107–2117. 70 indexed citations
15.
Iwabayashi, Masaaki, Yoshiaki Taniyama, Fumihiro Sanada, et al.. (2012). Inhibition of Lp(a)-induced functional impairment of endothelial cells and endothelial progenitor cells by hepatocyte growth factor. Biochemical and Biophysical Research Communications. 423(1). 79–84. 14 indexed citations
16.
Leistner, David M., Florian Seeger, Ariane Fischer, et al.. (2012). Elevated Levels of the Mediator of Catabolic Bone Remodeling RANKL in the Bone Marrow Environment Link Chronic Heart Failure with Osteoporosis. Circulation Heart Failure. 5(6). 769–777. 21 indexed citations
17.
Taniyama, Yoshiaki, Junya Azuma, Kazuma Iekushi, et al.. (2012). The HGF/c-Met Receptor System Under Pathological Conditions. Immunology Endocrine & Metabolic Agents - Medicinal Chemistry. 12(2). 122–129. 2 indexed citations
18.
Aßmus, Birgit, Masanori Iwasaki, Volker Schächinger, et al.. (2011). Acute myocardial infarction activates progenitor cells and increases Wnt signalling in the bone marrow. European Heart Journal. 33(15). 1911–1919. 52 indexed citations
19.
Boon, Reinier A., Kazuma Iekushi, Susanne Heydt, et al.. (2010). Abstract 14023: Inhibition of the Age-induced microRNA-34 Improves Recovery After AMI in Mice. Circulation. 122. 1 indexed citations
20.
Yoon, Chang‐Hwan, Masamichi Koyanagi, Kazuma Iekushi, et al.. (2010). Mechanism of Improved Cardiac Function After Bone Marrow Mononuclear Cell Therapy. Circulation. 121(18). 2001–2011. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrei Seferian Breakdown of academic impact, for papers by Neil Davie Breakdown of academic impact, for papers by Roger van Kruchten Breakdown of academic impact, for papers by Yukihiro Hojo Breakdown of academic impact, for papers by Mélanie Eyries Breakdown of academic impact, for papers by Pierre Zoldhelyi Breakdown of academic impact, for papers by Jay M. Edelberg Breakdown of academic impact, for papers by Benoît Ranchoux Breakdown of academic impact, for papers by Clément Nguyen Breakdown of academic impact, for papers by Yacine Boulaftali
Rankless by CCL
2026